Page 64 - Q BULLETIN, Ministry of Health Malaysia, VOLUME 1, NO. 31 (SUPPLEMENT 1), JAN-DEC 2022
P. 64

Q Bulletin, Volume 1, No. 31 (Supplement 1), Jan - Dec 2022
           th
          11  National QA Convention, 4 – 6 October 2022
          PP-26

          Reducing Blood Sample Rejection in Pathology Department, Institut Kanser Negara,
          Putrajaya


          Azilah AA, Rafidah A, Mohd Hakimi J, Shahirah Niza N, Siti Shahirah CM, Suhaila MH
          Jabatan Patologi, Institut Kanser Negara, Putrajaya

          SELECTION OF OPPORTUNITIES FOR IMPROVEMENT:
          Blood  sample  rejection  in  the  Pathology  Department  is  a  serious  issue  that  negatively  affects  patient
          management. Repetitions of blood draw cause pain and distress to the patient and consequently lead to wastage
          of cost and time. This study aims to minimise the rejection percentage of blood samples.


          KEY MEASURES FOR IMPROVEMENT:
          The key measures for improvement were measured by the percentage of blood sample rejection calculated
          monthly. The standard is <1% based on MSQH 5  edition: Service Standard 15 (Pathology Services).
                                                     th
          PROCESS OF GATHERING INFORMATION:
          A cross-sectional study was performed from January to December 2019. All blood samples received in the
          Pathology Department were included, and rejections were based on standardised rejection criteria. Monthly
          data of rejected samples and reasons for rejection were extracted from the Laboratory Information System
          (LIS). Implementation of remedial measures was carried out in May 2019, and post-remedial evaluation was
          conducted from June to December 2019.

          ANALYSIS AND INTERPRETATION:
          A verification study conducted from January to April 2019 showed the average rejection percentage was 1.61%,
          with Achievable Benefit Not Achieved (ABNA) being 0.61%. Sample rejections were due to haemolysed
          (57%), clotted (15%), insufficient samples (9%), and others.

          STRATEGIES FOR CHANGE:
          The Haemolysis Index Method was implemented, which accurately determines the degree of lysed samples.
          Only gross haemolysed samples with Haemolysis Index greater than 4+ were rejected. Other measures included
          Continuous Medical Education (CME), onsite visits, and refreshment training.

          EFFECT OF CHANGE:
          The Haemolysis Index Method has reduced the rejection of haemolysed samples, thus significantly reducing
          the total rejection percentage in the Pathology Department. Starting from June 2019, the rejection percentage
          was successfully brought down to 0.88%, suggesting the sustainability of remedial measures.

          THE NEXT STEP:
          All strategies will be continued to maintain the rejection percentage. Measurement of the Haemolysis Index
          will be incorporated for all samples as this will improve the quality of laboratory results.


















          60
   59   60   61   62   63   64   65   66   67   68   69